CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 32 filers reported holding CASI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $260,114 | -31.2% | 145,315 | 0.0% | 0.06% | -64.2% |
| Q3 2022 | $378,000 | -9.1% | 145,315 | -0.0% | 0.16% | +63.4% |
| Q2 2022 | $416,000 | -64.7% | 145,317 | -90.0% | 0.10% | -73.9% |
| Q1 2022 | $1,177,000 | +28.9% | 1,453,190 | +27.3% | 0.39% | +112.6% |
| Q4 2021 | $913,000 | -58.1% | 1,141,190 | -37.7% | 0.18% | -76.1% |
| Q3 2021 | $2,181,000 | -23.2% | 1,832,769 | 0.0% | 0.76% | -18.9% |
| Q2 2021 | $2,841,000 | -35.4% | 1,832,769 | 0.0% | 0.94% | -40.5% |
| Q1 2021 | $4,399,000 | -17.7% | 1,832,769 | +1.1% | 1.58% | -17.7% |
| Q4 2020 | $5,348,000 | +136.2% | 1,812,769 | +22.5% | 1.92% | +101.5% |
| Q3 2020 | $2,264,000 | -42.9% | 1,479,623 | -6.7% | 0.95% | -45.3% |
| Q2 2020 | $3,964,000 | +47.7% | 1,585,609 | +20.5% | 1.74% | +17.4% |
| Q1 2020 | $2,684,000 | -32.0% | 1,315,609 | +3.0% | 1.48% | -15.4% |
| Q4 2019 | $3,947,000 | +9.5% | 1,277,322 | +13.4% | 1.75% | +2.8% |
| Q2 2019 | $3,605,000 | +11.5% | 1,126,650 | 0.0% | 1.70% | +3.3% |
| Q1 2019 | $3,233,000 | -25.6% | 1,126,650 | +4.3% | 1.65% | -33.7% |
| Q4 2018 | $4,344,000 | +3.8% | 1,080,650 | +20.6% | 2.49% | +9.6% |
| Q3 2018 | $4,185,000 | -46.5% | 896,137 | -5.8% | 2.27% | -44.1% |
| Q2 2018 | $7,827,000 | +200.2% | 951,064 | +52.1% | 4.06% | +188.5% |
| Q1 2018 | $2,607,000 | +80.2% | 625,118 | +40.4% | 1.41% | +80.7% |
| Q4 2017 | $1,447,000 | +66.9% | 445,118 | -9.2% | 0.78% | +172.0% |
| Q3 2017 | $867,000 | +63.3% | 489,984 | -3.1% | 0.29% | +56.3% |
| Q2 2017 | $531,000 | -26.0% | 505,474 | 0.0% | 0.18% | -15.3% |
| Q1 2017 | $718,000 | +23.6% | 505,474 | 0.0% | 0.22% | -28.9% |
| Q4 2016 | $581,000 | +3.6% | 505,474 | 0.0% | 0.30% | +6.7% |
| Q3 2016 | $561,000 | -2.1% | 505,474 | +3.3% | 0.28% | -19.9% |
| Q2 2016 | $573,000 | +10.4% | 489,327 | 0.0% | 0.36% | +2.9% |
| Q1 2016 | $519,000 | +10.4% | 489,327 | 0.0% | 0.35% | +10.9% |
| Q4 2015 | $470,000 | -10.3% | 489,327 | -0.0% | 0.31% | -21.2% |
| Q3 2015 | $524,000 | -40.2% | 489,372 | 0.0% | 0.40% | +35.6% |
| Q2 2015 | $876,000 | +17.7% | 489,372 | -3.1% | 0.29% | -33.5% |
| Q1 2015 | $744,000 | +10.9% | 504,861 | 0.0% | 0.44% | +14.6% |
| Q4 2014 | $671,000 | -27.7% | 504,861 | -2.6% | 0.38% | -34.4% |
| Q3 2014 | $928,000 | -0.5% | 518,583 | 0.0% | 0.58% | 0.0% |
| Q2 2014 | $933,000 | – | 518,583 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 951,064 | $7,827,000 | 4.06% |
| Wellington Shields Capital Management, LLC | 855,056 | $7,037,000 | 1.16% |
| Manatuck Hill Partners, LLC | 15,090 | $124,000 | 0.05% |
| Moors & Cabot, Inc. | 22,935 | $187,000 | 0.02% |
| Perceptive Advisors | 43,682 | $360,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 120,000 | $988,000 | 0.01% |
| ALPS ADVISORS INC | 125,015 | $1,029,000 | 0.01% |
| MetLife Investment Management, LLC | 26,316 | $217,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 136,518 | $1,124,000 | 0.00% |
| Private Advisor Group, LLC | 15,001 | $122,000 | 0.00% |